Literature DB >> 3921759

Comparative pathology of the canine model of glycogen storage disease type II (Pompe's disease).

H C Walvoort, J A Dormans, T S van den Ingh.   

Abstract

The pathology of canine glycogen storage disease type II (acid alpha-glucosidase deficiency, GSD II) was studied in three genetically related Lapland dogs and compared to the pathology of human GSD II (McKusick 23230). Canine GSD II closely parallels the infantile form of the human disease, except for the presence of oesophageal dilatation. Generalized glycogen storage particularly affected muscular tissues (skeletal, oesophageal, cardiac and smooth muscle). The altered cells showed glycogen accumulation in the cytosol and in autophagic membrane-bound vacuoles (glycogenosomes). They also showed increased acid phosphatase activity consistent with the lysosomal nature of this storage disorder. The cytopathology in canine and human GSD II appears to evolve from segregation of glycogen during regular cellular autophagy, phagolysosomal accumulation of the undigested glycogen, and eventually rupture of distended glycogenosomes. This study indicates that the usefulness of canine GSD II as an animal model of human disease, extends to the area of pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921759     DOI: 10.1007/bf01805484

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  40 in total

Review 1.  INBORN LYSOSOMAL DISEASES.

Authors:  H G HERS
Journal:  Gastroenterology       Date:  1965-05       Impact factor: 22.682

2.  ELECTRON MICROSCOPIC STUDIES OF THE PROXIMAL TUBULE OF THE RAT KIDNEY. II. CYTOSEGRESOMES AND CYTOSOMES: THEIR RELATIONSHIP TO EACH OTHER AND TO THE LYSOSOME CONCEPT.

Authors:  J L ERICSSON; B F TRUMP; J WEIBEL
Journal:  Lab Invest       Date:  1965-07       Impact factor: 5.662

3.  Pompe's disease: ultrastructural alterations of muscle tissue in parents.

Authors:  G Pellegrini; G Mosca; C Cerri
Journal:  Acta Neurol Scand       Date:  1978-03       Impact factor: 3.209

4.  The effect of temperature on the pH stability of myosin ATPase as demonstrated histochemically.

Authors:  M A Khan; J M Papadimitriou; B A Kakulas
Journal:  Histochemie       Date:  1974-02-06

5.  Mechanism of glycogenosome formation in axons of cadmium-induced neuropathy--ultrastructural and biochemical studies.

Authors:  T Hamada; T Iwamasa; T Tsuru; K Sato; T Takeuchi
Journal:  Neurotoxicology       Date:  1981-01       Impact factor: 4.294

6.  Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation.

Authors:  T Iwamasa; S Fukuda; S Tokumitsu; N Ninomiya; I Matsuda; M Osame
Journal:  Exp Mol Pathol       Date:  1983-06       Impact factor: 3.362

7.  Adult-onset acid maltase deficiency: a postmortem study.

Authors:  S DiMauro; L Z Stern; M Mehler; R B Nagle; C Payne
Journal:  Muscle Nerve       Date:  1978 Jan-Feb       Impact factor: 3.217

8.  Generalised glycogenosis in Brahman cattle.

Authors:  B M O'Sullivan; P J Healy; I R Fraser; R E Nieper; R J Whittle; C A Sewell
Journal:  Aust Vet J       Date:  1981-05       Impact factor: 1.281

9.  [Pseudodystrophic muscle glycogenosis in adults. (Acid maltase deficiency syndrome) (author's transl)].

Authors:  F Gullotta; H Stefan; H Mattern
Journal:  J Neurol       Date:  1976       Impact factor: 4.849

10.  A histochemical and electron microscopic study of skeletal muscle in a case of Pompe's disease (glycogenosis II).

Authors:  R D Cardiff
Journal:  Pediatrics       Date:  1966-02       Impact factor: 7.124

View more
  7 in total

Review 1.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

2.  rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.

Authors:  Hanmeng Zhang; Murtaza S Nagree; Haoyuan Liu; Xiaoqing Pan; Jeffrey A Medin; Daniel M Lipinski
Journal:  Gene Ther       Date:  2022-07-28       Impact factor: 4.184

Review 3.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

4.  Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Authors:  Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng H Cheng; Lamya S Shihabuddin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

5.  Glycogen storage disease in a young cat with heart failure.

Authors:  Shigeki Tanaka; Ryohei Suzuki; Hidekazu Koyama; Noboru Machida; Akira Yabuki; Osamu Yamato
Journal:  J Vet Intern Med       Date:  2021-12-23       Impact factor: 3.333

6.  A nonsense mutation in the acid α-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds.

Authors:  Eija H Seppälä; Arnold J J Reuser; Hannes Lohi
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

7.  AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease.

Authors:  Francesca Gatto; Barbara Rossi; Antonietta Tarallo; Elena Polishchuk; Roman Polishchuk; Alessandra Carrella; Edoardo Nusco; Filomena Grazia Alvino; Francesca Iacobellis; Elvira De Leonibus; Alberto Auricchio; Graciana Diez-Roux; Andrea Ballabio; Giancarlo Parenti
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.